• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Drug Safety Oversight Board Meeting: October 2, 2007 Public Summary

The Board held a meeting at the request of the Director of the Center for Drug Evaluation and Research (CDER) to provide advice on an internal difference of opinion regarding a post-marketing safety concern and options for regulatory action.